BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18

• Press Releases

  Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets

  July 10, 2025

   · 

  2 min read
• Press Releases

  FluidForm Bio™ Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions

  July 10, 2025

   · 

  4 min read
• Press Releases

  Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity

  July 10, 2025

   · 

  13 min read
• Press Releases

  Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026

  July 10, 2025

   · 

  6 min read
• Press Releases

  KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

  July 10, 2025

   · 

  5 min read
• Press Releases

  New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials

  July 10, 2025

   · 

  5 min read
• Press Releases

  DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors

  July 10, 2025

   · 

  3 min read
• Press Releases

  MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025

  July 10, 2025

   · 

  1 min read
• Press Releases

  Amneal to Report Second Quarter 2025 Results on August 5, 2025

  July 10, 2025

   · 

  1 min read
• Press Releases

  ZEPBOUND™ KWIKPEN® (TIRZEPATIDE INJECTION), THE FIRST AND ONLY DUAL RECEPTOR AGONIST FOR THE TREATMENT OF OBESITY, NOW APPROVED AND AVAILABLE IN CANADA

  July 10, 2025

   · 

  8 min read